home All News open_in_new Full Article
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
today 5 h. ago attach_file Economics
attach_file
Culture
attach_file
Politics
attach_file
Sport
attach_file
Economics
attach_file
Other
attach_file
Science
attach_file
Economics
attach_file
Other
attach_file
Politics
attach_file
Events
attach_file
Other
ID: 1259929878